Cargando…
Intraarticular hemorrhage due to bevacizumab in a patient with metastatic colorectal cancer: a case report
INTRODUCTION: Bevacizumab is a monoclonal antibody against vascular endothelial growth factor. It is widely used in the treatment of metastatic colorectal cancer. It has some specific side effects including severe bleeding, wound healing problems, gastrointestinal perforation, proteinuria and hypert...
Autores principales: | Uysal, Mukremin, Goksu, Sema Sezgin, Coskun, Hasan Senol, Savas, Burhan, Ozdogan, Mustafa, Bozcuk, Hakan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464779/ https://www.ncbi.nlm.nih.gov/pubmed/22776219 http://dx.doi.org/10.1186/1752-1947-6-188 |
Ejemplares similares
-
Coexistence of Gastric Adenocarcinoma and Choriocarcinoma: Complete Response to Trastuzumab and Chemotherapy
por: Gunduz, Seyda, et al.
Publicado: (2012) -
Her-2 Positive Gastric Cancer Presented with Thrombocytopenia and Skin Involvement: A Case Report
por: Arslan, Deniz, et al.
Publicado: (2014) -
Use of chemotherapy at the end of life in Turkey
por: Sezgin Goksu, Sema, et al.
Publicado: (2014) -
Elucidating the correlation between treatment with tyrosine kinase inhibitors and mean platelet volume in patients with metastatic renal cell cancer
por: GUNDUZ, SEYDA, et al.
Publicado: (2014) -
Dystrophic Cutaneous Calcification and Metaplastic Bone Formation due to Long Term Bisphosphonate Use in Breast Cancer
por: Tatlı, Ali Murat, et al.
Publicado: (2013)